Budapest, Hungary

Pal Tolnay


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1980-1981

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Pal Tolnay

Introduction

Pal Tolnay is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address high blood pressure. With a total of 2 patents to his name, Tolnay's work is recognized for its potential impact on health and medicine.

Latest Patents

Tolnay's latest patents include innovative compounds known as 3-(1-Pyrazolyl)-pyridazine derivatives. These compounds are designed to decrease high blood pressure and inhibit the catabolism of prostaglandins. The formula includes variations where R.sup.1 can be hydrogen or a C.sub.1-4 alkyl group. Another significant patent involves hypotensive compositions that relate to compounds of a general formula where R.sup.1 can represent a hydrogen atom, a C.sub.1-6 alkyl, a C.sub.2-4 hydroxyalkyl, a C.sub.3-6 cycloalkyl, or a phenyl group.

Career Highlights

Pal Tolnay is associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on innovative solutions for medical challenges, particularly in the area of hypertension.

Collaborations

Throughout his career, Tolnay has collaborated with esteemed colleagues such as Geza Szilagyi and Endre Kasztreiner. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Pal Tolnay's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in medical science and offers hope for effective treatments for high blood pressure.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…